nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Estropipate—osteoporosis	0.165	0.518	CbGbCtD
Glimepiride—CYP2C9—Cholecalciferol—osteoporosis	0.0849	0.267	CbGbCtD
Glimepiride—CYP2C9—Estradiol—osteoporosis	0.0685	0.215	CbGbCtD
Glimepiride—Tension—Conjugated Estrogens—osteoporosis	0.00106	0.00156	CcSEcCtD
Glimepiride—Urticaria—Estropipate—osteoporosis	0.00106	0.00156	CcSEcCtD
Glimepiride—Vision blurred—Zoledronate—osteoporosis	0.00106	0.00155	CcSEcCtD
Glimepiride—Gastrointestinal pain—Raloxifene—osteoporosis	0.00106	0.00155	CcSEcCtD
Glimepiride—Diarrhoea—Etidronic acid—osteoporosis	0.00106	0.00155	CcSEcCtD
Glimepiride—Abdominal pain—Estropipate—osteoporosis	0.00106	0.00155	CcSEcCtD
Glimepiride—Feeling abnormal—Ibandronate—osteoporosis	0.00106	0.00155	CcSEcCtD
Glimepiride—Tremor—Zoledronate—osteoporosis	0.00105	0.00155	CcSEcCtD
Glimepiride—Nervousness—Conjugated Estrogens—osteoporosis	0.00105	0.00154	CcSEcCtD
Glimepiride—Gastrointestinal pain—Ibandronate—osteoporosis	0.00105	0.00154	CcSEcCtD
Glimepiride—Urticaria—Alendronate—osteoporosis	0.00105	0.00153	CcSEcCtD
Glimepiride—Anxiety—Pamidronate—osteoporosis	0.00104	0.00153	CcSEcCtD
Glimepiride—Abdominal pain—Alendronate—osteoporosis	0.00104	0.00153	CcSEcCtD
Glimepiride—Shock—Risedronate—osteoporosis	0.00104	0.00153	CcSEcCtD
Glimepiride—Anaemia—Zoledronate—osteoporosis	0.00104	0.00152	CcSEcCtD
Glimepiride—Agitation—Zoledronate—osteoporosis	0.00103	0.00152	CcSEcCtD
Glimepiride—Angioedema—Zoledronate—osteoporosis	0.00103	0.00151	CcSEcCtD
Glimepiride—Gastrointestinal pain—Calcitriol—osteoporosis	0.00103	0.00151	CcSEcCtD
Glimepiride—Abdominal pain—Raloxifene—osteoporosis	0.00102	0.0015	CcSEcCtD
Glimepiride—Vision blurred—Conjugated Estrogens—osteoporosis	0.00102	0.0015	CcSEcCtD
Glimepiride—Urticaria—Ibandronate—osteoporosis	0.00102	0.00149	CcSEcCtD
Glimepiride—Abdominal pain—Ibandronate—osteoporosis	0.00101	0.00149	CcSEcCtD
Glimepiride—Confusional state—Pamidronate—osteoporosis	0.00101	0.00149	CcSEcCtD
Glimepiride—Leukopenia—Zoledronate—osteoporosis	0.00101	0.00148	CcSEcCtD
Glimepiride—Anaphylactic shock—Pamidronate—osteoporosis	0.001	0.00147	CcSEcCtD
Glimepiride—Urticaria—Calcitriol—osteoporosis	0.000997	0.00146	CcSEcCtD
Glimepiride—Hepatitis—Estradiol—osteoporosis	0.000995	0.00146	CcSEcCtD
Glimepiride—Palpitations—Zoledronate—osteoporosis	0.000994	0.00146	CcSEcCtD
Glimepiride—Abdominal pain—Calcitriol—osteoporosis	0.000992	0.00146	CcSEcCtD
Glimepiride—Angioedema—Conjugated Estrogens—osteoporosis	0.000989	0.00145	CcSEcCtD
Glimepiride—Shock—Pamidronate—osteoporosis	0.000988	0.00145	CcSEcCtD
Glimepiride—Loss of consciousness—Zoledronate—osteoporosis	0.000988	0.00145	CcSEcCtD
Glimepiride—Hypersensitivity—Estropipate—osteoporosis	0.000985	0.00145	CcSEcCtD
Glimepiride—Thrombocytopenia—Pamidronate—osteoporosis	0.000984	0.00144	CcSEcCtD
Glimepiride—Vomiting—Etidronic acid—osteoporosis	0.000983	0.00144	CcSEcCtD
Glimepiride—Tachycardia—Pamidronate—osteoporosis	0.000981	0.00144	CcSEcCtD
Glimepiride—Rash—Etidronic acid—osteoporosis	0.000975	0.00143	CcSEcCtD
Glimepiride—Convulsion—Zoledronate—osteoporosis	0.000974	0.00143	CcSEcCtD
Glimepiride—Dermatitis—Etidronic acid—osteoporosis	0.000974	0.00143	CcSEcCtD
Glimepiride—Hyperhidrosis—Pamidronate—osteoporosis	0.000971	0.00142	CcSEcCtD
Glimepiride—Hypertension—Zoledronate—osteoporosis	0.000971	0.00142	CcSEcCtD
Glimepiride—Hypersensitivity—Alendronate—osteoporosis	0.00097	0.00142	CcSEcCtD
Glimepiride—Headache—Etidronic acid—osteoporosis	0.000968	0.00142	CcSEcCtD
Glimepiride—Asthenia—Estropipate—osteoporosis	0.00096	0.00141	CcSEcCtD
Glimepiride—Visual impairment—Estradiol—osteoporosis	0.000959	0.00141	CcSEcCtD
Glimepiride—Anorexia—Pamidronate—osteoporosis	0.000958	0.0014	CcSEcCtD
Glimepiride—Palpitations—Conjugated Estrogens—osteoporosis	0.000957	0.0014	CcSEcCtD
Glimepiride—Insomnia—Risedronate—osteoporosis	0.000956	0.0014	CcSEcCtD
Glimepiride—Anxiety—Zoledronate—osteoporosis	0.000954	0.0014	CcSEcCtD
Glimepiride—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000952	0.0014	CcSEcCtD
Glimepiride—Paraesthesia—Risedronate—osteoporosis	0.000949	0.00139	CcSEcCtD
Glimepiride—Pruritus—Estropipate—osteoporosis	0.000946	0.00139	CcSEcCtD
Glimepiride—Asthenia—Alendronate—osteoporosis	0.000945	0.00139	CcSEcCtD
Glimepiride—Hypersensitivity—Ibandronate—osteoporosis	0.000945	0.00139	CcSEcCtD
Glimepiride—Dyspnoea—Risedronate—osteoporosis	0.000942	0.00138	CcSEcCtD
Glimepiride—Erythema multiforme—Estradiol—osteoporosis	0.000941	0.00138	CcSEcCtD
Glimepiride—Hypotension—Pamidronate—osteoporosis	0.000939	0.00138	CcSEcCtD
Glimepiride—Convulsion—Conjugated Estrogens—osteoporosis	0.000938	0.00138	CcSEcCtD
Glimepiride—Dry mouth—Zoledronate—osteoporosis	0.000936	0.00137	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000936	0.00137	CcSEcCtD
Glimepiride—Fatigue—Ethinyl Estradiol—osteoporosis	0.000935	0.00137	CcSEcCtD
Glimepiride—Pruritus—Alendronate—osteoporosis	0.000932	0.00137	CcSEcCtD
Glimepiride—Dyspepsia—Risedronate—osteoporosis	0.00093	0.00136	CcSEcCtD
Glimepiride—Confusional state—Zoledronate—osteoporosis	0.000925	0.00136	CcSEcCtD
Glimepiride—Hypersensitivity—Calcitriol—osteoporosis	0.000925	0.00136	CcSEcCtD
Glimepiride—Asthenia—Ibandronate—osteoporosis	0.00092	0.00135	CcSEcCtD
Glimepiride—Anxiety—Conjugated Estrogens—osteoporosis	0.000919	0.00135	CcSEcCtD
Glimepiride—Nausea—Etidronic acid—osteoporosis	0.000918	0.00135	CcSEcCtD
Glimepiride—Anaphylactic shock—Zoledronate—osteoporosis	0.000918	0.00135	CcSEcCtD
Glimepiride—Diarrhoea—Estropipate—osteoporosis	0.000915	0.00134	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Risedronate—osteoporosis	0.000912	0.00134	CcSEcCtD
Glimepiride—Fatigue—Risedronate—osteoporosis	0.000911	0.00134	CcSEcCtD
Glimepiride—Insomnia—Pamidronate—osteoporosis	0.000909	0.00133	CcSEcCtD
Glimepiride—Pruritus—Ibandronate—osteoporosis	0.000907	0.00133	CcSEcCtD
Glimepiride—Shock—Zoledronate—osteoporosis	0.000903	0.00132	CcSEcCtD
Glimepiride—Paraesthesia—Pamidronate—osteoporosis	0.000902	0.00132	CcSEcCtD
Glimepiride—Diarrhoea—Alendronate—osteoporosis	0.000901	0.00132	CcSEcCtD
Glimepiride—Asthenia—Calcitriol—osteoporosis	0.000901	0.00132	CcSEcCtD
Glimepiride—Thrombocytopenia—Zoledronate—osteoporosis	0.000899	0.00132	CcSEcCtD
Glimepiride—Dyspnoea—Pamidronate—osteoporosis	0.000896	0.00131	CcSEcCtD
Glimepiride—Tachycardia—Zoledronate—osteoporosis	0.000896	0.00131	CcSEcCtD
Glimepiride—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000893	0.00131	CcSEcCtD
Glimepiride—Somnolence—Pamidronate—osteoporosis	0.000893	0.00131	CcSEcCtD
Glimepiride—Pruritus—Calcitriol—osteoporosis	0.000888	0.0013	CcSEcCtD
Glimepiride—Hyperhidrosis—Zoledronate—osteoporosis	0.000887	0.0013	CcSEcCtD
Glimepiride—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000886	0.0013	CcSEcCtD
Glimepiride—Diarrhoea—Raloxifene—osteoporosis	0.000886	0.0013	CcSEcCtD
Glimepiride—Dyspepsia—Pamidronate—osteoporosis	0.000884	0.0013	CcSEcCtD
Glimepiride—Dizziness—Estropipate—osteoporosis	0.000884	0.0013	CcSEcCtD
Glimepiride—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000884	0.0013	CcSEcCtD
Glimepiride—Diarrhoea—Ibandronate—osteoporosis	0.000877	0.00129	CcSEcCtD
Glimepiride—Anorexia—Zoledronate—osteoporosis	0.000875	0.00128	CcSEcCtD
Glimepiride—Decreased appetite—Pamidronate—osteoporosis	0.000873	0.00128	CcSEcCtD
Glimepiride—Dizziness—Alendronate—osteoporosis	0.000871	0.00128	CcSEcCtD
Glimepiride—Shock—Conjugated Estrogens—osteoporosis	0.000869	0.00128	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000867	0.00127	CcSEcCtD
Glimepiride—Erythema—Estradiol—osteoporosis	0.000867	0.00127	CcSEcCtD
Glimepiride—Malnutrition—Estradiol—osteoporosis	0.000867	0.00127	CcSEcCtD
Glimepiride—Fatigue—Pamidronate—osteoporosis	0.000866	0.00127	CcSEcCtD
Glimepiride—Gastrointestinal pain—Risedronate—osteoporosis	0.000864	0.00127	CcSEcCtD
Glimepiride—Tachycardia—Conjugated Estrogens—osteoporosis	0.000862	0.00127	CcSEcCtD
Glimepiride—Urticaria—Ethinyl Estradiol—osteoporosis	0.000861	0.00126	CcSEcCtD
Glimepiride—Diarrhoea—Calcitriol—osteoporosis	0.000859	0.00126	CcSEcCtD
Glimepiride—Hypotension—Zoledronate—osteoporosis	0.000858	0.00126	CcSEcCtD
Glimepiride—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000857	0.00126	CcSEcCtD
Glimepiride—Dizziness—Raloxifene—osteoporosis	0.000857	0.00126	CcSEcCtD
Glimepiride—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000854	0.00125	CcSEcCtD
Glimepiride—Tension—Estradiol—osteoporosis	0.00085	0.00125	CcSEcCtD
Glimepiride—Vomiting—Estropipate—osteoporosis	0.00085	0.00125	CcSEcCtD
Glimepiride—Dizziness—Ibandronate—osteoporosis	0.000848	0.00124	CcSEcCtD
Glimepiride—Rash—Estropipate—osteoporosis	0.000843	0.00124	CcSEcCtD
Glimepiride—Dermatitis—Estropipate—osteoporosis	0.000842	0.00124	CcSEcCtD
Glimepiride—Anorexia—Conjugated Estrogens—osteoporosis	0.000842	0.00124	CcSEcCtD
Glimepiride—Nervousness—Estradiol—osteoporosis	0.000842	0.00123	CcSEcCtD
Glimepiride—Urticaria—Risedronate—osteoporosis	0.00084	0.00123	CcSEcCtD
Glimepiride—Headache—Estropipate—osteoporosis	0.000838	0.00123	CcSEcCtD
Glimepiride—Vomiting—Alendronate—osteoporosis	0.000838	0.00123	CcSEcCtD
Glimepiride—Abdominal pain—Risedronate—osteoporosis	0.000836	0.00123	CcSEcCtD
Glimepiride—Rash—Alendronate—osteoporosis	0.000831	0.00122	CcSEcCtD
Glimepiride—Insomnia—Zoledronate—osteoporosis	0.00083	0.00122	CcSEcCtD
Glimepiride—Dermatitis—Alendronate—osteoporosis	0.00083	0.00122	CcSEcCtD
Glimepiride—Feeling abnormal—Pamidronate—osteoporosis	0.000828	0.00121	CcSEcCtD
Glimepiride—Hypotension—Conjugated Estrogens—osteoporosis	0.000826	0.00121	CcSEcCtD
Glimepiride—Headache—Alendronate—osteoporosis	0.000825	0.00121	CcSEcCtD
Glimepiride—Paraesthesia—Zoledronate—osteoporosis	0.000824	0.00121	CcSEcCtD
Glimepiride—Vomiting—Raloxifene—osteoporosis	0.000824	0.00121	CcSEcCtD
Glimepiride—Gastrointestinal pain—Pamidronate—osteoporosis	0.000822	0.00121	CcSEcCtD
Glimepiride—Dyspnoea—Zoledronate—osteoporosis	0.000818	0.0012	CcSEcCtD
Glimepiride—Rash—Raloxifene—osteoporosis	0.000817	0.0012	CcSEcCtD
Glimepiride—Dermatitis—Raloxifene—osteoporosis	0.000816	0.0012	CcSEcCtD
Glimepiride—Somnolence—Zoledronate—osteoporosis	0.000816	0.0012	CcSEcCtD
Glimepiride—Vomiting—Ibandronate—osteoporosis	0.000815	0.0012	CcSEcCtD
Glimepiride—Tremor—Estradiol—osteoporosis	0.000812	0.00119	CcSEcCtD
Glimepiride—Headache—Raloxifene—osteoporosis	0.000812	0.00119	CcSEcCtD
Glimepiride—Rash—Ibandronate—osteoporosis	0.000809	0.00119	CcSEcCtD
Glimepiride—Dermatitis—Ibandronate—osteoporosis	0.000808	0.00119	CcSEcCtD
Glimepiride—Dyspepsia—Zoledronate—osteoporosis	0.000808	0.00118	CcSEcCtD
Glimepiride—Headache—Ibandronate—osteoporosis	0.000803	0.00118	CcSEcCtD
Glimepiride—Insomnia—Conjugated Estrogens—osteoporosis	0.000799	0.00117	CcSEcCtD
Glimepiride—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000799	0.00117	CcSEcCtD
Glimepiride—Vomiting—Calcitriol—osteoporosis	0.000798	0.00117	CcSEcCtD
Glimepiride—Decreased appetite—Zoledronate—osteoporosis	0.000798	0.00117	CcSEcCtD
Glimepiride—Agitation—Estradiol—osteoporosis	0.000796	0.00117	CcSEcCtD
Glimepiride—Nausea—Estropipate—osteoporosis	0.000794	0.00117	CcSEcCtD
Glimepiride—Abdominal pain—Pamidronate—osteoporosis	0.000794	0.00117	CcSEcCtD
Glimepiride—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000794	0.00116	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000792	0.00116	CcSEcCtD
Glimepiride—Angioedema—Estradiol—osteoporosis	0.000792	0.00116	CcSEcCtD
Glimepiride—Rash—Calcitriol—osteoporosis	0.000792	0.00116	CcSEcCtD
Glimepiride—Fatigue—Zoledronate—osteoporosis	0.000791	0.00116	CcSEcCtD
Glimepiride—Dermatitis—Calcitriol—osteoporosis	0.000791	0.00116	CcSEcCtD
Glimepiride—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000788	0.00116	CcSEcCtD
Glimepiride—Headache—Calcitriol—osteoporosis	0.000786	0.00115	CcSEcCtD
Glimepiride—Somnolence—Conjugated Estrogens—osteoporosis	0.000786	0.00115	CcSEcCtD
Glimepiride—Nausea—Alendronate—osteoporosis	0.000782	0.00115	CcSEcCtD
Glimepiride—Hypersensitivity—Risedronate—osteoporosis	0.000779	0.00114	CcSEcCtD
Glimepiride—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000778	0.00114	CcSEcCtD
Glimepiride—Asthenia—Ethinyl Estradiol—osteoporosis	0.000778	0.00114	CcSEcCtD
Glimepiride—Nausea—Raloxifene—osteoporosis	0.000769	0.00113	CcSEcCtD
Glimepiride—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000768	0.00113	CcSEcCtD
Glimepiride—Pruritus—Ethinyl Estradiol—osteoporosis	0.000767	0.00112	CcSEcCtD
Glimepiride—Palpitations—Estradiol—osteoporosis	0.000766	0.00112	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000763	0.00112	CcSEcCtD
Glimepiride—Fatigue—Conjugated Estrogens—osteoporosis	0.000762	0.00112	CcSEcCtD
Glimepiride—Nausea—Ibandronate—osteoporosis	0.000762	0.00112	CcSEcCtD
Glimepiride—Loss of consciousness—Estradiol—osteoporosis	0.000762	0.00112	CcSEcCtD
Glimepiride—Asthenia—Risedronate—osteoporosis	0.000758	0.00111	CcSEcCtD
Glimepiride—Feeling abnormal—Zoledronate—osteoporosis	0.000756	0.00111	CcSEcCtD
Glimepiride—Gastrointestinal pain—Zoledronate—osteoporosis	0.00075	0.0011	CcSEcCtD
Glimepiride—Hypertension—Estradiol—osteoporosis	0.000748	0.0011	CcSEcCtD
Glimepiride—Pruritus—Risedronate—osteoporosis	0.000748	0.0011	CcSEcCtD
Glimepiride—Nausea—Calcitriol—osteoporosis	0.000746	0.00109	CcSEcCtD
Glimepiride—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000742	0.00109	CcSEcCtD
Glimepiride—Hypersensitivity—Pamidronate—osteoporosis	0.00074	0.00109	CcSEcCtD
Glimepiride—Anxiety—Estradiol—osteoporosis	0.000735	0.00108	CcSEcCtD
Glimepiride—Urticaria—Zoledronate—osteoporosis	0.000729	0.00107	CcSEcCtD
Glimepiride—Abdominal pain—Zoledronate—osteoporosis	0.000725	0.00106	CcSEcCtD
Glimepiride—Diarrhoea—Risedronate—osteoporosis	0.000723	0.00106	CcSEcCtD
Glimepiride—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000723	0.00106	CcSEcCtD
Glimepiride—Dry mouth—Estradiol—osteoporosis	0.000722	0.00106	CcSEcCtD
Glimepiride—Asthenia—Pamidronate—osteoporosis	0.000721	0.00106	CcSEcCtD
Glimepiride—Dizziness—Ethinyl Estradiol—osteoporosis	0.000717	0.00105	CcSEcCtD
Glimepiride—Confusional state—Estradiol—osteoporosis	0.000713	0.00105	CcSEcCtD
Glimepiride—Pruritus—Pamidronate—osteoporosis	0.000711	0.00104	CcSEcCtD
Glimepiride—Anaphylactic shock—Estradiol—osteoporosis	0.000707	0.00104	CcSEcCtD
Glimepiride—Urticaria—Conjugated Estrogens—osteoporosis	0.000702	0.00103	CcSEcCtD
Glimepiride—Dizziness—Risedronate—osteoporosis	0.000699	0.00103	CcSEcCtD
Glimepiride—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000699	0.00102	CcSEcCtD
Glimepiride—Shock—Estradiol—osteoporosis	0.000696	0.00102	CcSEcCtD
Glimepiride—Tachycardia—Estradiol—osteoporosis	0.00069	0.00101	CcSEcCtD
Glimepiride—Vomiting—Ethinyl Estradiol—osteoporosis	0.000689	0.00101	CcSEcCtD
Glimepiride—Diarrhoea—Pamidronate—osteoporosis	0.000687	0.00101	CcSEcCtD
Glimepiride—Hyperhidrosis—Estradiol—osteoporosis	0.000684	0.001	CcSEcCtD
Glimepiride—Rash—Ethinyl Estradiol—osteoporosis	0.000684	0.001	CcSEcCtD
Glimepiride—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000683	0.001	CcSEcCtD
Glimepiride—Headache—Ethinyl Estradiol—osteoporosis	0.000679	0.000996	CcSEcCtD
Glimepiride—Hypersensitivity—Zoledronate—osteoporosis	0.000676	0.000992	CcSEcCtD
Glimepiride—Vomiting—Risedronate—osteoporosis	0.000672	0.000986	CcSEcCtD
Glimepiride—Rash—Risedronate—osteoporosis	0.000666	0.000978	CcSEcCtD
Glimepiride—Dermatitis—Risedronate—osteoporosis	0.000666	0.000977	CcSEcCtD
Glimepiride—Dizziness—Pamidronate—osteoporosis	0.000664	0.000975	CcSEcCtD
Glimepiride—Headache—Risedronate—osteoporosis	0.000662	0.000971	CcSEcCtD
Glimepiride—Asthenia—Zoledronate—osteoporosis	0.000658	0.000966	CcSEcCtD
Glimepiride—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000651	0.000955	CcSEcCtD
Glimepiride—Pruritus—Zoledronate—osteoporosis	0.000649	0.000952	CcSEcCtD
Glimepiride—Nausea—Ethinyl Estradiol—osteoporosis	0.000644	0.000944	CcSEcCtD
Glimepiride—Insomnia—Estradiol—osteoporosis	0.00064	0.000938	CcSEcCtD
Glimepiride—Vomiting—Pamidronate—osteoporosis	0.000639	0.000937	CcSEcCtD
Glimepiride—Paraesthesia—Estradiol—osteoporosis	0.000635	0.000932	CcSEcCtD
Glimepiride—Asthenia—Conjugated Estrogens—osteoporosis	0.000634	0.00093	CcSEcCtD
Glimepiride—Rash—Pamidronate—osteoporosis	0.000634	0.000929	CcSEcCtD
Glimepiride—Dermatitis—Pamidronate—osteoporosis	0.000633	0.000928	CcSEcCtD
Glimepiride—Dyspnoea—Estradiol—osteoporosis	0.000631	0.000925	CcSEcCtD
Glimepiride—Headache—Pamidronate—osteoporosis	0.000629	0.000923	CcSEcCtD
Glimepiride—Somnolence—Estradiol—osteoporosis	0.000629	0.000922	CcSEcCtD
Glimepiride—Diarrhoea—Zoledronate—osteoporosis	0.000628	0.000921	CcSEcCtD
Glimepiride—Nausea—Risedronate—osteoporosis	0.000628	0.000921	CcSEcCtD
Glimepiride—Pruritus—Conjugated Estrogens—osteoporosis	0.000625	0.000917	CcSEcCtD
Glimepiride—Dyspepsia—Estradiol—osteoporosis	0.000623	0.000913	CcSEcCtD
Glimepiride—Decreased appetite—Estradiol—osteoporosis	0.000615	0.000902	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Estradiol—osteoporosis	0.000611	0.000896	CcSEcCtD
Glimepiride—Fatigue—Estradiol—osteoporosis	0.00061	0.000894	CcSEcCtD
Glimepiride—Dizziness—Zoledronate—osteoporosis	0.000607	0.00089	CcSEcCtD
Glimepiride—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000605	0.000887	CcSEcCtD
Glimepiride—Nausea—Pamidronate—osteoporosis	0.000597	0.000875	CcSEcCtD
Glimepiride—Dizziness—Conjugated Estrogens—osteoporosis	0.000584	0.000857	CcSEcCtD
Glimepiride—Vomiting—Zoledronate—osteoporosis	0.000584	0.000856	CcSEcCtD
Glimepiride—Feeling abnormal—Estradiol—osteoporosis	0.000583	0.000855	CcSEcCtD
Glimepiride—Rash—Zoledronate—osteoporosis	0.000579	0.000849	CcSEcCtD
Glimepiride—Gastrointestinal pain—Estradiol—osteoporosis	0.000578	0.000848	CcSEcCtD
Glimepiride—Dermatitis—Zoledronate—osteoporosis	0.000578	0.000848	CcSEcCtD
Glimepiride—Headache—Zoledronate—osteoporosis	0.000575	0.000843	CcSEcCtD
Glimepiride—Vomiting—Conjugated Estrogens—osteoporosis	0.000562	0.000824	CcSEcCtD
Glimepiride—Urticaria—Estradiol—osteoporosis	0.000562	0.000824	CcSEcCtD
Glimepiride—Abdominal pain—Estradiol—osteoporosis	0.000559	0.00082	CcSEcCtD
Glimepiride—Rash—Conjugated Estrogens—osteoporosis	0.000557	0.000817	CcSEcCtD
Glimepiride—Dermatitis—Conjugated Estrogens—osteoporosis	0.000557	0.000817	CcSEcCtD
Glimepiride—Headache—Conjugated Estrogens—osteoporosis	0.000554	0.000812	CcSEcCtD
Glimepiride—Nausea—Zoledronate—osteoporosis	0.000545	0.0008	CcSEcCtD
Glimepiride—Nausea—Conjugated Estrogens—osteoporosis	0.000525	0.00077	CcSEcCtD
Glimepiride—Hypersensitivity—Estradiol—osteoporosis	0.000521	0.000764	CcSEcCtD
Glimepiride—Asthenia—Estradiol—osteoporosis	0.000507	0.000744	CcSEcCtD
Glimepiride—Pruritus—Estradiol—osteoporosis	0.0005	0.000734	CcSEcCtD
Glimepiride—Diarrhoea—Estradiol—osteoporosis	0.000484	0.00071	CcSEcCtD
Glimepiride—Dizziness—Estradiol—osteoporosis	0.000468	0.000686	CcSEcCtD
Glimepiride—Vomiting—Estradiol—osteoporosis	0.00045	0.00066	CcSEcCtD
Glimepiride—Rash—Estradiol—osteoporosis	0.000446	0.000654	CcSEcCtD
Glimepiride—Dermatitis—Estradiol—osteoporosis	0.000446	0.000654	CcSEcCtD
Glimepiride—Headache—Estradiol—osteoporosis	0.000443	0.00065	CcSEcCtD
Glimepiride—Nausea—Estradiol—osteoporosis	0.00042	0.000616	CcSEcCtD
